Related Experiment Videos
Merkel cell tumor in an HIV-positive patient
J P Catlett1, W M Todd, M E Carr
1Division of Hematology/Oncology, Medical College of Virginia/Virginia Commonwealth University, Richmond.
Virginia Medical Quarterly : VMQ
|January 11, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Monitoring rFVIIa 90 μg kg⁻¹ dosing in haemophiliacs: comparing laboratory response using various whole blood assays over 6 h.
Haemophilia : the official journal of the World Federation of Hemophilia·2011
Effect of recombinant factor VIIa variant (NN1731) on platelet function, clot structure and force onset time in whole blood from healthy volunteers and haemophilia patients.
Haemophilia : the official journal of the World Federation of Hemophilia·2007
Percutaneous liver biopsy in adult haemophiliacs with hepatitis C virus: safety of outpatient procedure and impact of human immunodeficiency virus coinfection on the spectrum of liver disease.
Haemophilia : the official journal of the World Federation of Hemophilia·2007
Thrombin generation time is a novel parameter for monitoring enoxaparin therapy in patients with end-stage renal disease.
Journal of thrombosis and haemostasis : JTH·2006
Onset of force development as a marker of thrombin generation in whole blood: the thrombin generation time (TGT).
Journal of thrombosis and haemostasis : JTH·2003
Thrombolytic therapy for acute ischemic stroke.
Virginia medical quarterly : VMQ·1998
Diagnosis of stroke.
Virginia medical quarterly : VMQ·1998
A woman in medicine. From the 1940s to the 1990s. A personal saga.
Virginia medical quarterly : VMQ·1998
Women in medicine: shaping the future.
Virginia medical quarterly : VMQ·1998
Hyper-Intense Tumor Peripheral Accumulation of Antibody-Conjugated Iron Oxide Nanoparticles can Enable Breast Cancer Detection by Magnetic Particle Imaging.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Interpretation of p53 immunohistochemical stain of TP53-mutated myeloid neoplasms.
Frontiers in oncology·2026